5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Hikal Ltd.

•
hikal.comBSE: 524735NSE: HIKAL
Market Cap₹ 2,773 Cr.
Current Price
High / Low₹ 283 / 146
Stock P/E0.0
Book Value₹ 97
Price to Book1.51
Dividend Yield0.27 %
ROCE-0.8 %
ROE-4.0 %
Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Pharmaceuticals: 59.6% • Crop Protection: 40.4%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 6.89x)
  • Company generates healthy free cash flow
  • Company has a consistent dividend-paying track record

CONS

  • Company is loss-making at the operating / net level
  • Recent results are weak - TTM profit is down 160.8% versus prior year
  • Company has a low return on equity of 3.2% over last 3 years
  • Company has a low return on capital employed of 5.6%
  • Interest coverage is weak at -0.3x - earnings barely cover interest
  • Company's sales have been declining over the last five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.HIKAL224.900.002773.030.27-7.4066.96402.808.48-0.829.19
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
386431438513404451439550371316491517403
338377383420349378376429356311412414424
Operating Profit4854569355736312116579103-21
OPM %12.54%12.48%12.73%18.14%13.65%16.10%14.45%22.02%4.23%1.61%16.12%19.96%-5.14%
1100004012-35-40-7
Interest14131415201919181715161515
Depreciation28292932323233383941414243
Profit before Tax101722477252468-31-47-98-10
Tax %28.87%25.60%25.35%28.39%25.71%26.42%27.62%26.46%26.06%25.85%35.87%-71.76%25.00%
Net Profit71216345181750-23-35-615-8
0.561.021.322.750.421.471.404.08-1.84-2.81-0.481.18-0.61

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,0141,2961,5901,5071,7201,9432,0231,7851,8601,7131,727
8171,0541,2911,2341,3981,6021,7661,5181,5311,4921,560
Operating Profit197242298273323341257267328220167
OPM %19.45%18.65%18.75%18.12%18.77%17.53%12.71%14.96%17.66%12.88%9.65%
342-1255525-73-81
Interest4849585236314856756260
Depreciation698693828596109118134164167
Profit before Tax8311114912720621910595124-78-58
Tax %15.08%30.73%30.86%33.29%35.50%26.56%25.61%27.15%26.63%37.72%41.74%
Net Profit717710384133161787091-49-34
EPS8.556.268.366.8510.8013.026.365.637.36-3.94—
Dividend Payout %13.96%12.77%14.35%17.52%18.52%12.29%18.88%21.32%19.02%-15.22%—

COMPOUNDED SALES GROWTH

10 Years:
6%
5 Years:
0%
3 Years:
-5%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

STOCK PRICE CAGR

10 Years:
7%
5 Years:
-19%
3 Years:
-9%
1 Year:
-13%

RETURN ON EQUITY

10 Years:
10%
5 Years:
7%
3 Years:
3%
Last Year:
-4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2018

Jun 22

1:2

& Bonus issue Inter alia, has transacted the following: 1. The Board of Directors of the Company subject to approval of members of the Company in the ensuing Extra Ordinary General Meeting, recommended issue of Bonus Shares to the members of the Company by capitalisation of its reserves in the ratio of 1:2 i.e. one bonus equity share of Rs. 2/- each fully paid-up for every two existing equity share of Rs. 2/- each fully paid-up held by the members as on a record date to be fixed hereafter for the purpose. 2. Recommended Final Dividend for the Financial Year 2017-18 on Equity Share Capital @ 25% [Re.0.50 per equity share (nominal value Rs. 2/- each)] on expanded capital base (on account of Bonus issue) at their meeting held on May 09, 2018, aggregating to dividend of 60% (Rs. 1.20 per equity share) {including Interim Dividend of Re. 0.70 per share (Seventy Paise Only) (35%) paid to the shareholders on March 01 2018}, subject to the approval of shareholders in the ensuing Annual General Meeting (AGM). Final Dividend, if approved by the shareholders at the ensuing AGM to be held on August 08, 2018, will be paid to the shareholders within 30 days of AGM date.

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital16162525252525252525
5896537327929091,0431,1091,1631,2381,174
550574600562515589707773692606
Trade Payables130165160201230249313279304266
114190259300338422232524271294
Total Liabilities1,4001,5971,7751,8792,0162,3282,3852,7632,5292,365
6686347137357138799481,0711,3641,333
Capital Work in Progress621167315224528540241412194
4311111551010
264303364312267329317304334358
2011233550522442
Cash & Bank16273264374960211814
384515591614752772650398159115
Total Assets1,4001,5971,7751,8792,0162,3282,3852,7632,5292,365

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
183165218325276364344187280302
Cash from Investing-103-110-125-164-156-284-292-174-136-145
Cash from Financing-63-25-55-101-97-6-8-27-144-160
-24620-24415-140-3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
68.8568.8568.8568.8568.8568.8568.8568.8568.85
6.666.786.065.705.354.232.311.440.98
3.173.583.483.804.035.157.057.207.23
Government0.000.000.000.000.000.000.000.000.00
21.3220.7921.6121.6621.7721.7621.7922.5222.93

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-02
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-02 - Hikal Limited has informed the Exchange about Schedule of meet

2026-09-01
Copy of Newspaper Publication

2026-09-01 - Hikal Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-31
General Updates

2026-08-31 - Hikal Limited has informed the Exchange about General Updates

2026-08-31
General Updates

2026-08-31 - Hikal Limited has informed the Exchange about General Updates

2026-08-31
Shareholders meeting

2026-08-31 - Hikal Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

2026-08-27
Updates

2026-08-27 - Hikal Limited has informed the Exchange regarding 'Communication to Shareholders-Intimation of Tax Deduction on Dividend'.

2026-08-27
Copy of Newspaper Publication

2026-08-27 - Hikal Limited has informed the Exchange about Copy of Newspaper Publication regarding information about 38th Annual General Meeting of the Company and other related information.

2026-08-26
General Updates

2026-08-26 - Hikal Limited has informed the Exchange about General Updates

2026-08-26
Record Date

2026-08-26 - Hikal Limited has informed the Exchange that Record date for the purpose of Dividend is 04-Sep-2026.

News

Recent coverage and analyst commentary for HIKAL

Loading news…

🤖

AI Stock Analyst

Hikal Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login